Insider Transactions in Q3 2021 at Alexion Pharmaceuticals, Inc. (ALXN)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 21
2021
|
John J Orloff EVP, Research & Development |
SELL
Sale (or disposition) back to the issuer
|
Direct |
146,511
-100.0%
|
-
|
|
Jul 21
2021
|
Ludwig Hantson CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
580,809
-98.46%
|
-
|
|
Jul 21
2021
|
Andreas Rummelt Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
28,109
-100.0%
|
-
|
|
Jul 21
2021
|
Francois Nader Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,921
-100.0%
|
-
|
|
Jul 21
2021
|
Indrani Lall Franchini EVP, Chief Compliance Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
116,075
-100.0%
|
-
|
|
Jul 21
2021
|
Daniel Bazarko SVP, Controller, CAO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
60,207
-100.0%
|
-
|
|
Jul 21
2021
|
Ellen Chiniara EVP & Chief Legal Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
116,850
-100.0%
|
-
|
|
Jul 21
2021
|
Brian Goff EVP & Chief Commercial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
150,832
-100.0%
|
-
|
|
Jul 21
2021
|
David R Brennan Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
20,873
-100.0%
|
-
|
|
Jul 21
2021
|
John T Mollen Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
15,336
-100.0%
|
-
|
|
Jul 21
2021
|
Tanisha Carino EVP & CCAO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
59,226
-100.0%
|
-
|
|
Jul 21
2021
|
Deborah Dunsire Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,629
-100.0%
|
-
|
|
Jul 21
2021
|
Judith A Reinsdorf Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,150
-100.0%
|
-
|
|
Jul 21
2021
|
Paul A Friedman Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,840
-100.0%
|
-
|
|
Jul 21
2021
|
Aradhana Sarin EVP, CFO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
120,253
-100.0%
|
-
|
|
Jul 21
2021
|
Christopher J Coughlin Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
42,347
-100.0%
|
-
|
|
Jul 14
2021
|
Brian Goff EVP & Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,144
+18.26%
|
-
|
|
Jul 14
2021
|
Tanisha Carino EVP & CCAO |
BUY
Grant, award, or other acquisition
|
Direct |
25,813
+30.35%
|
-
|
|
Jul 14
2021
|
Ellen Chiniara EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
54,469
+21.13%
|
-
|
|
Jul 14
2021
|
John J Orloff EVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
60,144
+18.76%
|
-
|
|
Jul 14
2021
|
Daniel Bazarko SVP, Controller, CAO |
BUY
Grant, award, or other acquisition
|
Direct |
21,708
+16.64%
|
-
|
|
Jul 14
2021
|
Indrani Lall Franchini EVP, Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
52,625
+20.55%
|
-
|
|
Jul 14
2021
|
Aradhana Sarin EVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
56,313
+21.25%
|
-
|
|
Jul 14
2021
|
Ludwig Hantson CEO |
BUY
Grant, award, or other acquisition
|
Direct |
240,741
+18.67%
|
-
|